Profound Medical Announces Board Resignation and New Appointment

The latest announcement is out from Profound Medical ( (TSE:PRN) ).

On March 5, 2026, Profound Medical Corp. announced that director Kris Shah resigned from its Board of Directors, effective immediately, with the company stating the departure was not due to any disagreement. The Board simultaneously appointed Frank Baylis to fill the vacancy, with Baylis to serve until the 2026 annual meeting and to receive standard non-employee director compensation, including a pro-rated $50,000 annual retainer, equity eligibility and customary indemnification, with no related-party ties or material related transactions disclosed.

The most recent analyst rating on (TSE:PRN) stock is a Hold with a C$7.50 price target. To see the full list of analyst forecasts on Profound Medical stock, see the TSE:PRN Stock Forecast page.

Spark’s Take on TSE:PRN Stock

According to Spark, TipRanks’ AI Analyst, TSE:PRN is a Neutral.

The score is held down primarily by weak financial performance (large losses and significant cash burn) and bearish technicals (downtrend across key moving averages with negative momentum). The earnings call adds support via credible growth/profitability targets, reimbursement and pipeline tailwinds, while valuation remains constrained by ongoing losses and no stated dividend.

To see Spark’s full report on TSE:PRN stock, click here.

More about Profound Medical

Profound Medical Corp. operates in the medical technology sector, focusing on advanced therapeutic solutions for healthcare providers and patients. The company is governed by a Board of Directors that includes non-employee members who receive cash retainers and equity-based compensation for their oversight roles.

Average Trading Volume: 18,956

Technical Sentiment Signal: Strong Sell

Current Market Cap: C$256.6M

Find detailed analytics on PRN stock on TipRanks’ Stock Analysis page.